{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-090389","form_type":"8-K","ticker":null,"cik":"0001251769","company_name":"Apollo Endosurgery, Inc.","filed_at":"2023-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.205363+00:00","generated_at":"2026-06-17T06:20:48.954057+00:00","sec_items":["1.02","2.01","2.04","3.01","3.03","5.01","5.02","5.03","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Apollo Endosurgery completes Boston Scientific acquisition for $10 per share cash","bullets":["Merger closed April 4, 2023; shareholders received $10.00 per share in cash.","Shares suspended from Nasdaq; Company to file Form 15 to suspend SEC reporting.","Entire board of directors and all executive officers resigned; replaced by Boston Scientific designees.","Loan and Security Agreement with Innovatus Life Sciences terminated and paid in full.","All outstanding stock options and RSUs cashed out; PSUs vested at target at merger close."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-090389","json":"https://secwatch.observer/filing/0001193125-23-090389.json","markdown":"https://secwatch.observer/filing/0001193125-23-090389.md","text":"https://secwatch.observer/filing/0001193125-23-090389.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/d464566d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T06:20:48.954057+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7754de4df03450efae6402cac7d6d6a3bdfcafd1","claim":"Apollo Endosurgery, Inc. faced acceleration on debt of approximately $1.9 million with Solar Capital LTD..","evidence_excerpt":"As previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, approximately $1.9 million is due and payable by the Company to Solar Capital LTD. in connection with the consummation of the Merger.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Principal","value":"approximately $1.9 million"},{"label":"Counterparty","value":"Solar Capital LTD."},{"label":"Event","value":"acceleration"}],"fact_type":"debt_financing"},{"claim_id":"014e149b39","claim":"Jeannette Bankes departed as director at Apollo Endosurgery, Inc..","evidence_excerpt":"each of Charles McKhann, John Barr, Jeannette Bankes, Julie Shimer, Ph.D., William D. McClellan, Jr., R. Kent McGaughy, Jr., David C. Pacitti and Sharon O’Keefe, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"}],"fact_type":"executive_change"},{"claim_id":"016da9dd84","claim":"Sharon O'Keefe departed as director at Apollo Endosurgery, Inc..","evidence_excerpt":"each of Charles McKhann, John Barr, Jeannette Bankes, Julie Shimer, Ph.D., William D. McClellan, Jr., R. Kent McGaughy, Jr., David C. Pacitti and Sharon O’Keefe, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"}],"fact_type":"executive_change"},{"claim_id":"0a27ce4e53","claim":"Julie Shimer departed as director at Apollo Endosurgery, Inc..","evidence_excerpt":"each of Charles McKhann, John Barr, Jeannette Bankes, Julie Shimer, Ph.D., William D. McClellan, Jr., R. Kent McGaughy, Jr., David C. Pacitti and Sharon O’Keefe, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"}],"fact_type":"executive_change"},{"claim_id":"0b1bb9b875","claim":"Vance R. Brown was appointed as Director at Apollo Endosurgery, Inc..","evidence_excerpt":"each of Vance R. Brown and Jonathan R. Monson, comprising all of the members of the board of directors of Merger Sub as of immediately prior to the Effective Time, became a member of the Company’s board of directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"became a member"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"2cd5080a00","claim":"Jeffrey Black resigned as other_named_officer at Apollo Endosurgery, Inc..","evidence_excerpt":"each of Charles McKhann, Jeffrey Black and John Molesphini, comprising all of the Company’s executive officers, resigned as an officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"}],"fact_type":"executive_change"},{"claim_id":"3121053298","claim":"David C. Pacitti departed as director at Apollo Endosurgery, Inc..","evidence_excerpt":"each of Charles McKhann, John Barr, Jeannette Bankes, Julie Shimer, Ph.D., William D. McClellan, Jr., R. Kent McGaughy, Jr., David C. Pacitti and Sharon O’Keefe, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"}],"fact_type":"executive_change"},{"claim_id":"3b576f5f6a","claim":"Jonathan R. Monson was appointed as Director at Apollo Endosurgery, Inc..","evidence_excerpt":"each of Vance R. Brown and Jonathan R. Monson, comprising all of the members of the board of directors of Merger Sub as of immediately prior to the Effective Time, became a member of the Company’s board of directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"became a member"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"4db02dceac","claim":"John Molesphini resigned as other_named_officer at Apollo Endosurgery, Inc..","evidence_excerpt":"each of Charles McKhann, Jeffrey Black and John Molesphini, comprising all of the Company’s executive officers, resigned as an officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"}],"fact_type":"executive_change"},{"claim_id":"7e9ed96719","claim":"Charles McKhann departed as director at Apollo Endosurgery, Inc..","evidence_excerpt":"each of Charles McKhann, John Barr, Jeannette Bankes, Julie Shimer, Ph.D., William D. McClellan, Jr., R. Kent McGaughy, Jr., David C. Pacitti and Sharon O’Keefe, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"}],"fact_type":"executive_change"},{"claim_id":"a6b2e277ab","claim":"William D. McClellan departed as director at Apollo Endosurgery, Inc..","evidence_excerpt":"each of Charles McKhann, John Barr, Jeannette Bankes, Julie Shimer, Ph.D., William D. McClellan, Jr., R. Kent McGaughy, Jr., David C. Pacitti and Sharon O’Keefe, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"}],"fact_type":"executive_change"},{"claim_id":"c0aeccb338","claim":"Charles McKhann resigned as other_named_officer at Apollo Endosurgery, Inc..","evidence_excerpt":"each of Charles McKhann, Jeffrey Black and John Molesphini, comprising all of the Company’s executive officers, resigned as an officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"}],"fact_type":"executive_change"},{"claim_id":"d68ec57252","claim":"John Barr departed as director at Apollo Endosurgery, Inc..","evidence_excerpt":"each of Charles McKhann, John Barr, Jeannette Bankes, Julie Shimer, Ph.D., William D. McClellan, Jr., R. Kent McGaughy, Jr., David C. Pacitti and Sharon O’Keefe, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"}],"fact_type":"executive_change"},{"claim_id":"e96cfa486e","claim":"R. Kent McGaughy departed as director at Apollo Endosurgery, Inc..","evidence_excerpt":"each of Charles McKhann, John Barr, Jeannette Bankes, Julie Shimer, Ph.D., William D. McClellan, Jr., R. Kent McGaughy, Jr., David C. Pacitti and Sharon O’Keefe, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"}],"fact_type":"executive_change"},{"claim_id":"81136a4cb0ad3ebbe790d9c31c6b0ad8f603bc3b","claim":"Apollo Endosurgery, Inc. underwent a change of control involving Boston Scientific Corporation for $10.00 per share in cash (closed 2023-04-04).","evidence_excerpt":"Time, have neither effectively withdrawn nor lost their rights to such appraisal and payment under the DGCL), in each case, was canceled and converted into the right to receive $10.00 in cash, without interest (the “Merger Consideration”); (ii) outstanding and unexercised option to purchase Shares granted under any Company stock plan (each, a “Company Option”)","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"change of control"},{"label":"Counterparty","value":"Boston Scientific Corporation"},{"label":"Consideration","value":"$10.00 per share in cash"},{"label":"Closing","value":"2023-04-04"}],"fact_type":"ma_transaction"},{"claim_id":"87ee0303bce2d26af9cee0a61e6e73a8c9ece131","claim":"Apollo Endosurgery, Inc. terminated Loan Agreement with Innovatus Life Sciences Lending Fund I, LP as collateral agent, the lenders listed on Schedule 1.1 thereto, and the Company and certain of the Company’s subsidiaries, as co-borrowers (effective 2023-04-04).","evidence_excerpt":"On April 4, 2023, in connection with the consummation of the Merger, the Company paid in full all outstanding obligations under, and terminated, the Loan and Security Agreement, dated as of December 21, 2021 (as amended, extended, supplemented or otherwise modified from time to time, the “Loan Agreement”), by and among Innovatus Life Sciences Lending Fund I, LP as collateral agent, the lenders listed on Schedule 1.1 thereto, and the Company and certain of the Company’s subsidiaries, as co-borrowers.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1251769/000119312523090389/0001193125-23-090389-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Innovatus Life Sciences Lending Fund I, LP as collateral agent, the lenders listed on Schedule 1.1 thereto, and the Company and certain of the Company’s subsidiaries, as co-borrowers"},{"label":"Effective","value":"2023-04-04"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}